is tirzepatide a dual agonist Novel Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review Tirzepatide, a dual GIP/GLP-1 receptor

Neither platform integrates genetic pathway testing into routine assessment, but both collect metabolic and behavioral data that can inform personalized dosing and monitoring

Baseline testing and periodic monitoring help catch any changes early

This pattern mirrors what we see with other weight loss medications and may relate to differences in baseline body composition

Nausea is the most frequently reported, along with vomiting, diarrhea, constipation, stomach pain, and gas

This physician-guided approach offers an alternative to traditional weight loss programs

This is my take on it, combined with my experience coaching women for over 16 years